Management of hepatorenal syndrome and associated outcomes: a systematic reviews.
Jamshid RoozbehShahrokh Ezzatzadegan JahromiMohamad Hossein RezazadehAnahid HamidianjahromiLeila MalekmakanPublished in: BMJ open gastroenterology (2024)
This review showed that terlipressin has a significantly higher reversal rate of HRS than the other treatments. Even the results showed that terlipressin is more efficient than midodrine/octreotide and norepinephrine as a previous medication, in reverse HRS, increasing patient survival.